International travel continues to increase in numbers and complexity. Despite the availability of pretravel health advice, travelers remain at risk for exposure to common organisms as well as emerging pathogens. With low rates of travel clinic utilization, it is important for the general practitioner to remain aware of the importance of travel health, risk factors unique to individual patients, and evolving threats. This review highlights important considerations when evaluating ill travelers, incorporating emerging infectious threats.
rates below 50%, and in one small study, only 9% of Hong Kong travelers received pretravel ad vice. 1,5,7,13-16 However, even in the context of pre travel counseling and receipt of appropriate pre ventive measures, the rates of morbidity remain high with up to 75% of patients reporting illness during travel in one prospective cohort. 1 The most common categories of illnesses report ed in travelers are gastrointestinal syndromes, fe brile illnesses, dermatologic disorders, and respi ratory illnesses. 4,5,15,17 The spectrum of potential pathogens causing these syndromes is incredibly broad, and emerging threats should be considered. The impact of international travel on the visited population and the population to which the travel er returns should also be considered. Internation al travel may contribute to the spread of disease and disease emergence, in some settings. 18 Travel ers have been explicitly implicated in the spread of severe acute respiratory syndrome, influenza H1N1 virus, measles, mumps, dengue, malaria, and chol era, to name a few. 5, 19, 20 In the setting of increasing international trav el, traveler complexity, expanding destinations, low rates of pretravel counseling, and broad infec tious differentials, primary care providers must become more aware of risk factors for acquisition of infection and emerging threats when evalu ating international travelers. In this review, we highlight important considerations when evalu ating travelers, with a special focus on the risk of emerging infectious diseases, by placing clinical syndromes in a travel context. Background International travel continues to explode, with over 1 billion international tourist arrivals per year 1,2 and an estimated 2 billion by 2030. 3, 4 As a risk factor for infectious diseases, international travel has become an increasingly complex issue. Reasons for travel are numerous, and the spectrum of destinations has expanded with increasing travel to developing countries, namely, in Asia and Africa. 1,2,4,5 While most in ternational travel is for leisure, other reasons in clude business, education and research, volunteer work, visiting friends and relatives (VFR), med ical tourism, adoption, as well as immigration and military activities, all of which have their own unique risks. 4 -8 Additionally, travelers them selves are increasingly diverse. Travelers of all ages, immunocompromised travelers, and trav elers with comorbid conditions frequent high risk destinations. 6,9 -12 The percentage of travelers who become ill rang es significantly in published studies (6%-87%), al though a recently published review concluded that 43% to 79% of travelers who visited developing countries became ill. 4 These numbers are affect ed by patient expectations from travel (whether they choose to present to care because of travel associated illness) and regional patterns of dis ease (those who reside in metropolises close to a threat may experience it already). Despite high rates of morbidity associated with travel to de veloping countries, most travelers do not seek pretravel counseling. The exact proportion varies considerably by study, but most reports showed month of transmission in South America, reflect ing the rainy seasons in these locations. 25 Dry weather also carries specific infectious risks. In sub Saharan Africa, the incidence of meningo coccal meningitis increases every dry season. 26 Additionally, providers should be aware of known outbreaks (whether it is violence or infec tious diseases) and other hazards near the spots included in a patient's itinerary. Notifications of outbreaks can be found on the CDC, ECDC, or WHO websites. Outbreaks and unrest often are delineated on the websites of ministries of for eign affairs. In 2019, notable outbreaks include Ebola virus disease in the Democratic Republic of the Congo (DRC), with related risk in neighbor ing countries; Middle East respiratory syndrome coronavirus (MERS CoV) in Oman and Saudi Arabia; a worldwide measles outbreak; and chol era in several locations. Realized risk for emerg ing infectious diseases in the broad population of short term travelers has been low. Although early cases in Europe of MERS CoV were associ ated with Umrah, several large scale studies ex amining Hajj and Umrah have failed to identify cases. 21,27,28 Nonetheless, when it is realized, it is very impactful. South Korea experienced a con sequential nosocomial MERS CoV outbreak as sociated with a single short term traveler, and to a lesser extent so did the United States from Eb ola Zaire virus. 29-31
Travel is a common precipitating theme in Dis ease Outbreak News reports for micro outbreaks. 32 In many of these instances, the traveler was ex posed to an established, recognized outbreak. The purpose of their travel brought them in close proximity to areas of risk, and so a broad appli cation of usual traveler preparation coupled with risk communication regarding emerging disease events, and careful agreement about steps to take on return if ill, would be beneficial in risk manage ment in similar cases. Respiratory disease from novel or emerging influenzas and coronaviruses such as severe acute respiratory syndrome coro navirus are notable exceptions to this. All travel ers should understand that the unexpected occurs and that travel becomes part of their history of present illness or past medical history, as appro priate. In counseling a traveler, reassurance that travel can be safe with proper precautions should not attenuate vigilance with illness on return by both the provider and patient.
Patient vulnerabilities Important patient char acteristics to consider include age, pre existing medical conditions or comorbidities, and reasons for travel. Among travelers enrolled in the Global TravEpiNet, the age range was broad (1 month to 94 years) with a median age of 34 years. 6 While increasing age is generally associated with more underlying medical conditions, and subsequent ly increased risk of becoming ill when traveling, one study found that older travelers complied more with medical advice, took fewer risks, and had lower rates of illness compared with younger Risk of exposure In epidemiologic studies, time spent with an exposure dominates risk profiles. Whether counseling a would be traveler or eval uating one who has returned with a concern, ear ly in the interview an exposure assessment is re quired. What did the person actually do when on travel? Where was this done in terms of the setting and season, not just location? How did the person prepare for potential risks? Why a person chooses to travel, what they intended to do, what they might have done because op portunities arose? These issues are all vital to assessing risk. One particular example of this is VFR travelers. Research has consistently demon strated a higher risk of acquiring infection in this group, which in many cases is preventable. 21 In the United States, higher rates of hospitalization were noted among VFR travelers presenting to GeoSentinel clinics. 22 These travelers have lower rates of pretravel health visits and longer stays, which likely contributes to these differences. 22, 23 A traveler's specific reason for travel and trav el itinerary can unveil unique risk factors as well. Medical care, adoption, freshwater activities, vis iting or caring for the ill, medical tourism, sex tourism, refugee and other aid work, missionary work, activities at altitude, diving, food sources, and accommodations all contribute to a milieu in which travel related disease may be acquired or nontravel related disease may be exacerbated. In a study on travelers consulting a travel medi cine clinic, 83% of over 700 respondents report ed at least 1 risk behavior, and younger travelers in general participated in more risky behaviors. 24 Geographic locations have their own individu al risks. GeoSentinel surveillance has document ed variable risks for certain infectious syndromes by geographic region. For instance, malaria was the most common cause of systemic febrile illness after travel to sub Saharan Africa, while dengue was more frequent for all other locations except sub Saharan Africa and Central America. 8 Fur thermore, certain risks may be confined to spe cific areas or subregions even if they are common ly considered to be more broadly present. For ex ample, yellow fever is endemic to specific tropical areas of Africa and Central and South America. Detailed information about these regions is avail able to providers through the United States Cen ters for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Con trol (ECDC), World Health Organization (WHO), and other national level public health agencies.
Similarly, malaria is present in specific geo graphic locations, with absence of transmission at higher altitudes where the vector, the Anophe les mosquito, is not encountered. Seasonal varia tion is also an important consideration. GeoSen tinel surveillance revealed significant season al variation in dengue transmission, with more cases reported from September to December in South Central Asia with a peak in October. Rates in the Caribbean were highest between Au gust and December, while March was the peak This information is important for risk communi cation of the significance of layered preventative measures such as those against mosquito and food borne illnesses, for addressing preventative misconceptions of patients and providers rele vant to risk behavior (such as the false idea that any single prevention step done alone is enough), and for properly characterizing illness in returned travelers. For instance, the protective efficacy of available typhoid vaccination is low and ranges from 50% to 55%. 45 On the other hand, the pro tective efficacy of hepatitis A, B, rabies, MMR, and varicella vaccinations is high, though none of them is perfectly protective in every individ ual. 46 While often effective, the actual efficacy of medication prophylaxis against malaria can vary widely by circumstance, and the utility of doxy cycline for preventing leptospirosis remains un clear. 47 Despite this, most infections associated with travel are preventable, particularly those as sociated with travel to Africa. 2,48
Fever in a traveler: a clinical syndrome in context
Physicians who evaluate ill returned travelers also must place events in the context of recent travel. The first steps towards this are defining the clini cal syndrome and assessing the incubation period for risks specific to both cosmopolitan and geo graphical areas. As physicians, the presenting clin ical syndrome is the gateway to our understand ing of the patient's experience with an illness. What accompanies the patient's fever-cough, diarrhea, rash, lymphadenopathy, hepatospleno megaly, mental status change? Where has the pa tient been and when-sometimes over months to years but generally in terms of the last couple of weeks, several weeks, and longer? 49,50 Some of these relationships are presented in TABLE 1. How do they come together with the patient's travel behaviors and other factors to suggest how pri oritizing the most dangerous and most likely di agnoses impacts management?
A common pitfall in how this thinking is ap plied is to forget common infectious and nonin fectious illnesses that may occur anywhere. Any one can experience influenza. Travelers may ex perience intravascular thrombi, vaccine reactions and other hypersensitivity reactions, consequenc es of disruptions in chronic disease management, cancer (particularly breast, testicular, and hema tologic in younger travelers), rheumatic diseases, such as systemic lupus erythematosus, and every thing else that happens to people regardless of whether they are risk takers or because they are risk takers. Work-travel routine may disrupt usu al healthcare use and increase the risk for hard to manage conditions while on travel, such as human papilloma virus and shingles vaccination, routine oncologic and cardiovascular screening, and dental maintenance.
Investigating returned travelers with a fever may pose a challenge to usual clinical laboratory processes. Assessing samples for parasitic diseas es may require specialized techniques with which travelers (19% vs 34%). 33 According to Global TravEpiNet data, over half of all travelers in a sin gle analysis reported 1 or more medical conditions and taking at least 1 daily medication. 6 Similarly, a large cross sectional study in the greater Bos ton area found 74% of travelers had medical co morbidities, 18% were considered high risk, and 23% were immunocompromised. 12 Identification of persons with pre existing medical conditions and immune compromising conditions is important, as research suggests higher incidence of a travel related illness in in dividuals with pre existing medical conditions and higher rates of hospitalization in immuno compromised individuals when an illness occurs during travel. 34-36 The number of living immuno compromised persons is expected to increase, es pecially as indications for biologic agents expand, such as monoclonal antibodies used to treat rheu matologic and oncologic conditions. A study eval uating 486 immunocompromised international travelers seen at Global TravEpiNet sites found that biologic agents such as tumor necrosis factor inhibitors were the most commonly used immu nosuppressive medications. 36 Not only are these individuals at increased risk of complications re lated to infection, but pretravel live vaccinations may be contraindicated (ie, yellow fever or mea sles, mumps, rubella). Also, the extent to which a traveler's activities and stress may contribute to becoming ill when traveling is underappreci ated. Pre combat stress has well documented im pact on disease and non-battle injury rates among deployed service members. 37 An increased rate of upper respiratory tract infections with commen surate functional immunodeficiency has been ob served in athletes. 38 While travelers often do not seek pretravel health advice, when they do, sources often in clude general practitioners, family and friends, and the internet, with low utilization of travel clinics. 17,39,40 However, even in the setting of ap propriate counseling and preventive measures, the rates of morbidity remain high. 1 Studies have demonstrated low rates of insect repellent uti lization, vaccine series completion, and proper utilization of malaria prophylaxis among travel ers. 13, [41] [42] [43] To what extent VFR travelers tighten their selection of water sources and use of hand washing in cholera zones, or defer ritualistic fu neral practices in regions with Ebola virus, for in stance, is unknown. Nonetheless, tailored advice relevant to emerging infectious diseases events should be incorporated along with usual guid ance on maintaining wellness while traveling, when relevant to the itinerary. For some travel ers, their very activity may uniquely precipitate increased exposure to an emerging infectious dis ease, as occurred with leptospirosis among ad venture athletes from around the world in one notable event. 44 Recommended preventive measures are part of an important layered approach in travel risk man agement. In isolation, they have variable efficacy. Patient Zed arrived in Rwanda 10 days before presentation along with her husband and a group of friends who sponsored an eastern Rwanda vil lage as part of a twin or sister city relationship. While they paid visits to homes, churches, and restaurants, the group stayed in a guest house even a referral academic medical center may not be acquainted. 51 The local regulatory status of tropical disease assays, such as those for lepto spirosis or dengue fever, or of emerging diseas es, may vary. It is useful for physicians to discuss these issues with their laboratorian counterparts in advance. While awaiting a definitive diagnosis, clinicians sometimes try to rely on the presence or absence of arcane fever patterns, such as tertiary and quaternary fever patterns that require para site synchronization in different types of malar ia; pulse temperature disassociation in typhoid fever and other illness of the reticuloendothelial system; or saddle back patterns in dengue fever. While these may be informative, their individu al predictive power is low. This is not an exhaustive list but rather a frame of reference for initial assessment. 3,49,50 An individual patient might present with almost any sepsis clinical syndrome regardless of pathogen, and host factors may attenuate or exacerbate what normally would be a more characteristic syndrome. Patients may have more than 1 problem, for example, bacterial coinfection following a viral syndrome and occurring seemingly late. A fever and rash or arthralgia are not included, though borrelia, rickettsioses, meningococcemia, syphilis, typhoid, and viral hemorrhagic fever (VHF) are commonly associated with the former, and flaviviruses (eg, Dengue and Zika), alphaviruses (eg, Chikungunya), and borrelioses with either or both a rash and arthralgia. Malaria and VHF should be included in the broader differential diagnosis of fever and diarrhea. 
Incubation period
Less than 2 weeks 2 to 6 weeks More than 6 weeks potential risk for fall and its consequences at her age if she gets further behind in volume status, you prescribe a brief course of antibacterial ther apy, though you appreciate that other providers might reasonably wait another day and follow her symptoms. Thinking about her normal tempera ture (although in the upper part of the range) and that not all people's perceptions of what adher ence means with antimalarial preventive medi cations are the same, you decide that you will call her by telephone tomorrow to make sure that she has not manifested a fever, her symptomatology is improving, and that her group has not shown more illness. She is not a food handler, daycare provider, or healthcare worker, and so you are not concerned about occupational restrictions from a potentially communicable enteric disease.
Over the remainder of the day, you consider how the visit and day would have been different if the patient had been a healthcare missionary closer to the DRC, a fever had been present, and she had looked a bit sicker, or if she had present ed from an area with novel influenza or had small farm poultry exposure in Asia or camel or inpa tient hospital contact in the Middle East and was experiencing cough, or was a long time health care missionary and presented with cough and weight loss. You reflect that your concerns about potential connection to a public health emergen cy did not appear in the clinic until PZ had regis tered at the desk, spent time in the waiting area interacting with other patients, undergone tri age, possibly used the bathroom or patient water cooler, and come through to your office. Your clin ic staff decides to have an end of day debrief on the event and introduce signage so that patients self identify immediately when communicable symptoms are present regardless of an itinerary or a potential pathogen (eg, cough, rhinorrhea, diarrhea, vomiting, bleeding), or an itinerary or contact of concern; make handwashing and masks readily available in the waiting room; and gener ate procedures for how to proceed when risk is recognized. Additionally, you review the process for alerting and seeking counsel from local public health authorities, generate an explicit procedure for contacting them incorporating their required forms, when appropriate, and have an exploratory call with those authorities to test that procedure. You reflect on the original pretravel counseling you provided to PZ and whether current circum stances would have made that counseling differ ent, then implementing those changes system atically. You also think about the pervasive trav el threats that more commonly impact travelers, such as motor vehicle accidents, heat injury, in sufficient preparation for chronic disease man agement or urgent and emergent care, and how to ensure that they remain a key part of pretrav el counseling and preparation even when focus increases on emerging infectious diseases events. Summary Travel is an enriching and valuable activity. It should be undertaken appreciating accustomed to foreign travelers. They spent 1 day in a local game park. She is not aware of having had sick contacts and says that she was mindful of safer eating and drinking practices, vector mitiga tion with permethrin treated clothes and wearing mosquito repellent, has adhered to her antima larial medication prescription, and felt well until the onset of her symptom's yesterday. She thinks that she might have eaten a dodgy snack at the airport prior to boarding her flight home 2 days ago. She had no exposure to fresh water. Review of the patient's triage card shows an oral temper ature of 37.5ºC, a heart rate of 95 bpm, and nor mal blood pressure, respiratory rate, and pulse ox imetry. You had observed her enter the room and she had a normal, rapid gait. In the chair oppo site you she conversed comfortably. She appears to be of European descent.
As you are ready to perform a physical exami nation while suspecting a traveler's diarrhea from an enterotoxigenic Escherichia coli or a similar per vasive threat, you recall that cases of Ebola vi rus have been recently reported in Goma (DRC), which abuts the Rwandan border. 52,53 You remem ber your conversation with PZ prior to her trip and discussing that Rwanda was considered a high priority for preparedness activities, though it had not experienced an observed case. You check the CDC travel notices portal and see no warn ings listed for Rwanda. 54 Knowing that situa tions like that in the DRC change quickly, you also check the WHO Disease Outbreak News and see an update on the DRC from 3 days ago that said there were no confirmed cases outside the DRC. 32 You start rising from your desk as a Twitter feed alert appears on the task bar of your screen, and it is from the WHO Director General confirming that cases have been found in South Kivu near the Rwandan border. This raises the risk for Rwan da of experiencing the current emergency, but it has not been observed yet. Taking a closer look at an online map, the place where your traveler visited is well away from the DRC border. None theless, you ask the patient another set of ques tions about healthcare associated work, ritual practices during the visit, and the health of her fellow travelers. Her responses were unremark able, although she said that on reflection sev eral members of her group had mild abdominal symptoms yesterday morning while on layover for a connecting flight home. But none of them were as bad as hers and seemed to self resolve. They all had shared the dodgy airport snack.
Feeling reassured, you complete the physical examination, which is normal other than very mild abdominal discomfort with deep palpation. While washing your hands and reminding your pa tient to do so regularly, you ask your staff to pro vide her with oral rehydration solution followed by water, and within 45 minutes in the waiting room, her symptoms of orthostasis are gone and her heart rate is 80 bpm. While she did not expe rience a bowel movement during the visit, given the severity of her symptoms overnight as well as
